Please login to the form below

Not currently logged in
Email:
Password:

Nigel Brooksby joins Health Information as deputy chair

Chair of UK Life Sciences Council adds pharma experience to patient information organisation

Nigel Brooksby has been appointed deputy chair at Health Information, a UK-based company that aims to provide and circulate patient information to improve compliance.

Brooksby, who is also currently chair of the UK Life Sciences Council, brings almost 40 years of experience in the pharma industry to the firm, which has recently secured funding from MVM Life Science Partners.

Other current positions currently held by Brooksby include board advisor at Doctors.net.uk, board strategic advisor at Healthcare at Home, director at Novocta Biosystems and advisor to the Wellcome Trust.

Previously, he was chair and MD at Sanofi UK and president of the UK's Association of the British Pharmaceutical Industry (ABPI).

Commenting on his new role, Brooksby said he was interested in the benefits that the improved provision of information could have on patient compliance.

He said: “There is a real need for patients to understand their conditions and medicines better, and Health Information has helped millions of patients to do this. I am looking forward to the opportunity to help develop this success further.”

Dr Grace Lomax, co-founder of Health Information, said “I am thrilled that Nigel is joining us.  His experience in the pharmaceutical industry will enable us to support more patients, and to fortify our leading position in the UK market.”

20th February 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....

Infographics